Type 2 lepra reaction in Adult
Alerts and Notices
Important News & Links
Synopsis
Lepra reactions are acute or subacute inflammatory episodes in patients with leprosy, characterized by cutaneous and systemic involvement, caused by the sudden alteration in immune response. These reactions may occur at any time during the course of the disease but most frequently in the first 1-3 years after starting multidrug therapy. Reactions are responsible for almost all of the acute symptoms arising in association with leprosy. Three types of reactions are identified: type 1 lepra reaction, type 2 lepra reaction, and Lucio phenomenon. Type 1 and type 2 reactions affect 30%-50% of patients with leprosy during the course of the disease.
Type 2 lepra reaction, also called erythema nodosum leprosum (ENL), is caused by humoral immune complex formation and deposition. It is a multisystem disorder with a tendency for recurrence, and patients with lepromatous (LL) and borderline (BL) leprosy are most commonly affected. Studies have reported that about 15% of LL cases develop type 2 lepra reactions, and around 39%-77% of cases have multiple episodes of type 2 reaction with an average of 2.6 episodes per patient. Other risk factors for type 2 reactions include hormonal changes in women that come with puberty, pregnancy, and lactation.
Sudden-onset crops of tender, erythematous, painful subcutaneous nodules appear on the face, or symmetrically on extensor surfaces of the upper and lower extremities. Bullous or necrotic forms may be seen. Reactions typically lasts from 1-2 weeks; they may recur or persist over months.
Prompt diagnosis and treatment of lepra reactions is necessary to prevent significant neurologic morbidity and disability.
Type 2 lepra reaction, also called erythema nodosum leprosum (ENL), is caused by humoral immune complex formation and deposition. It is a multisystem disorder with a tendency for recurrence, and patients with lepromatous (LL) and borderline (BL) leprosy are most commonly affected. Studies have reported that about 15% of LL cases develop type 2 lepra reactions, and around 39%-77% of cases have multiple episodes of type 2 reaction with an average of 2.6 episodes per patient. Other risk factors for type 2 reactions include hormonal changes in women that come with puberty, pregnancy, and lactation.
Sudden-onset crops of tender, erythematous, painful subcutaneous nodules appear on the face, or symmetrically on extensor surfaces of the upper and lower extremities. Bullous or necrotic forms may be seen. Reactions typically lasts from 1-2 weeks; they may recur or persist over months.
Prompt diagnosis and treatment of lepra reactions is necessary to prevent significant neurologic morbidity and disability.
Codes
ICD10CM:
B92 – Sequelae of leprosy
SNOMEDCT:
240410002 – Type 2 lepra reaction
B92 – Sequelae of leprosy
SNOMEDCT:
240410002 – Type 2 lepra reaction
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
References
Subscription Required
Last Reviewed:08/28/2024
Last Updated:09/16/2024
Last Updated:09/16/2024